Ion Exchange (india) Ltd. · NSE:IONEXCHANG
Ion Exchange (india) — Q3 FY2023 Earnings Presentation
24 slides from Ion Exchange (india)'s earnings presentation, Feb 6, 2023
Slide 1: Covering letter to stock exchanges
February 6, 2023 To To BSE Limited National Stock Exchange of India Limited The Corporate Relationship Dept. Exchange Plaza, C-1, Block- G, P.J. Towers, Dalal Street Bandra Kurla Complex, Bandra (East), Mumbai-400 001 Mumbai-400 051 Scrip Code: 500214 Scrip Code: IONEXCHANG Sub: Submission of Analys
Slide 2: Earnings Presentation – Q3 / 9M-FY23
EARNINGS PRESENTATION – Q3 / 9M-FY23
Slide 3: Executive Summary
Executive Summary • Ion Exchange (India) Ltd (Ion Exchange), formed in 1964, is a pioneer in water, waste water treatment & environment solutions and caters to various industries, institutions, homes & communities. • Headquartered in Mumbai, the company has seven manufacturing & assembly facilities
Slide 4: Company Overview
Company Overview • Ion Exchange was originally formed as a subsidiary of Permutit, UK in 1964. It became a wholly owned FY22 REVENUE BREAKUP* Indian company in 1985. The company is currently in its 59th Year of operations. • The company has expanded its footprints globally and possesses a diversifie
Slide 5: Q3 / 9M-FY23 Financial Highlights
Q3 / 9M-FY23 Financial Highlights Q3-FY23 Performance (Standalone) Q3-FY23 Performance (Consolidated) INR 4,961 Mn INR 606 Mn 12.22% INR 5,121 Mn INR 625 Mn 12.20% Operating Income Operating EBITDA Operating EBITDA Operating Income Operating EBITDA Operating EBITDA Margins Margins INR 474 Mn 9.55% I
Slide 6: Q3 / 9M-FY23 Operational Highlights
Q3 / 9M-FY23 Operational Highlights ENGINEERING • The company witnessed steady order flows both in domestic and international market. • Regarding Sri Lanka order, whilst the execution remained significantly affected, the discussions are continuing for an acceptable way forward for expediting the pro
Slide 7: Financial Overview
FINANCIAL OVERVIEW,
Slide 8: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance INCOME STATEMENT (INR MN) Q3-FY23 Q3-FY22 Y-o-Y Q2-FY23 Q-o-Q Operating Income 4,961 3,784 31.1% 4,177 18.8% Expenses 4,355 3,359 29.7% 3,737 16.5% Operating EBITDA 606 425 42.6% 440 37.7% Operating EBITDA Margins (%) 12.22% 11.23% 99 Bps 10.53% 169 Bps Dep
Slide 9: Quarterly Standalone Segmental Breakup
Quarterly Standalone Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) 3,117 1,500 457 R 1,353 E 352 2,184 V E N U E Q3-FY22 Q3-FY23 Q3-FY22 Q3-FY23 Q3-FY22 Q3-FY23 269 385 Q3-FY22 Q3-FY23 E 283 B (3) I 131 T (16) Q3-FY22 Q3-FY23 Q3-FY22 Q3-FY23 8
Slide 10: YTD Standalone Financial Performance
YTD Standalone Financial Performance INCOME STATEMENT (INR MN) 9M-FY23 9M-FY22 Y-o-Y Operating Income 12,717 10,437 21.8% Expenses 11,342 9,250 22.6% Operating EBITDA 1,375 1,187 15.8% Operating EBITDA Margins (%) 10.81% 11.37% (56) Bps Depreciation 209 201 4.0% Finance Cost 48 57 (15.8)% Other Inco
Slide 11: YTD Standalone Segmental Breakup
YTD Standalone Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 7,353 1,416 4,375 6,015 3,824 E V 941 E N U E 9M-FY22 9M-FY23 9M-FY22 9M-FY23 9M-FY22 9M-FY23 1,039 9M-FY22 9M-FY23 821 E B 489 381 I T (19) 9M-FY22 9M-FY23 9M-FY22 9M-FY23 (23) 10
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance INCOME STATEMENT (INR MN) Q3-FY23 Q3-FY22 Y-o-Y Q2-FY23 Q-o-Q Operating Income 5,121 3,882 31.9% 4,476 14.4% Expenses 4,496 3,455 30.1% 3,943 14.0% Operating EBITDA 625 427 46.4% 533 17.3% Operating EBITDA Margins (%) 12.20% 11.00% 120 Bps 11.91% 29 Bps D
Slide 13: Quarterly Consolidated Segmental Breakup
Quarterly Consolidated Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 3,263 457 1,467 1,515 E 2,168 352 V E N U E Q3-FY22 Q3-FY23 Q3-FY22 Q3-FY23 Q3-FY22 Q3-FY23 378 Q3-FY22 Q3-FY23 310 308 E (2) B I 113 T (15) Q3-FY22 Q3-FY23 Q3-FY22 Q3-FY23 12
Slide 14: YTD Consolidated Financial Performance
YTD Consolidated Financial Performance INCOME STATEMENT (INR MN)43.0% 9M-FY23 9M-FY22 Y-o-Y Operating Income 13,421 10,805 24.2% Expenses 11,935 9,623 24.0% Operating EBITDA 1,486 1,182 25.7% Operating EBITDA Margins (%) 11.07% 10.94% 13 Bps Depreciation 217 210 3.3% Finance Cost 69 75 (8)% Other In
Slide 15: YTD Consolidated Segmental Breakup
YTD Consolidated Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) 1,416 R 7,864 E 4,568 6,143 4,065 V 941 E N U E 9M-FY22 9M-FY23 9M-FY22 9M-FY23 9M-FY22 9M-FY23 572 9M-FY22 9M-FY23 1,068 E 863 B 336 I T (16) (20) 9M-FY22 9M-FY23 9M-FY22 9M-FY23 14
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW
Slide 17: Historical Standalone Financial Performance
Historical Standalone Financial Performance INCOME STATEMENT (INR MN) FY19 FY20 FY21 FY22 9M-FY23 Operating Income 11,023 14,072 14,018 15,094 12,717 Expenses 10,110 12,862 12,067 13,123 11,342 Operating EBITDA 913 1,210 1,951 1,971 1,375 Operating EBITDA Margins (%) 8.28% 8.60% 13.92% 13.06% 10.81%
Slide 18: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet PARTICULARS (INR MN) FY21 FY22 H1-FY23 PARTICULARS (INR MN) FY21 FY22 H1-FY23 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Property, Plant and Equipment 1,421 1,389 1,410 (A) Equity Share Capital 147 147 147 (B) Capital Work-in-progress 146 200 254
Slide 19: Historical Consolidated Financial Performance
Historical Consolidated Financial Performance INCOME STATEMENT (INR MN) FY19 FY20 FY21 FY22 9M-FY23 Operating Income 11,623 14,798 14,495 15,769 13,421 Expenses 10,557 13,453 12,472 13,637 11,935 Operating EBITDA 1,066 1,345 2,023 2,132 1,486 Operating EBITDA Margins (%) 9.17% 9.09% 13.96% 13.52% 11
Slide 20: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet PARTICULARS (INR MN) FY21 FY22 H1-FY23 PARTICULARS (INR MN) FY21 FY22 H1-FY23 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 142 142 142 (A) Property, Plant and Equipment 1,486 1,446 1,469 (B) Capital Work-in-progress 146 200 25
Slide 21: Consolidated Financial Performance
Consolidated Financial Performance REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) 2,132 14,798 14,495 15,769 2,023 1,617 13,421 1,433 11,623 1,486 1,138 1,345 1,066 942 13.96% 13.52% 659 9.89% 10.25% 11.02% 8.48% 9.17% 9.09% 6.37% 5.67% FY19 FY20 FY21 FY22 9M-FY23 FY19 FY20 FY21 FY22 9M-FY
Slide 22: Market Data (Bloomberg – ION IN, Reuters – IONX.BO)
Market Data (Bloomberg – ION IN, Reuters – IONX.BO) 1 YEAR SHARE PRICE MOVEMENT (UP TO 31st December 2022) 50% 40% 30% 20% 10% 0% -10% -20% -30% Jan-22 Feb-22 Mar-22 Apr-22 May-22 Jun-22 Jul-22 Aug-22 Sep-22 Oct-22 Nov-22 Dec-22 Ion Exchange Sensex PRICE DATA (As on 31st December 2022) SHAREHOLDING
Slide 23: Disclaimer
Disclaimer Ion Exchange (India) Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all e
Slide 24: Thank You
THANK YOU
Ion Exchange (India) — Q3 FY2023 Earnings Presentation on 6ix